BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tang L, Mei Y, Shen Y, He S, Xiao Q, Yin Y, Xu Y, Shao J, Wang W, Cai Z. Nanoparticle-Mediated Targeted Drug Delivery to Remodel Tumor Microenvironment for Cancer Therapy. Int J Nanomedicine 2021;16:5811-29. [PMID: 34471353 DOI: 10.2147/IJN.S321416] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 17.0] [Reference Citation Analysis]
Number Citing Articles
1 Barani M, Rahdar A, Mukhtar M, Razzaq S, Qindeel M, Hosseini Olam SA, Paiva-santos AC, Ajalli N, Sargazi S, Balakrishnan D, Gupta AK, Pandey S. Recent application of cobalt ferrite nanoparticles as a theranostic agent. Materials Today Chemistry 2022;26:101131. [DOI: 10.1016/j.mtchem.2022.101131] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Al-anbari HH, Mahdi ZA, Zandi H, Karimi M. Investigating a nickel-decorated fullerene for adsorbing tespa anticancer: drug delivery assessments. J Mol Model 2022;28:390. [DOI: 10.1007/s00894-022-05385-4] [Reference Citation Analysis]
3 Li R, Chen Z, Li J, Dai Z, Yu Y. Nano-drug delivery systems for T cell-based immunotherapy. Nano Today 2022;46:101621. [DOI: 10.1016/j.nantod.2022.101621] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Lu C, Zhang C. Oxaliplatin inhibits colorectal cancer progression by inhibiting CXCL11 secreted by cancer-associated fibroblasts and the CXCR3/PI3K/AKT pathway. Clin Transl Oncol 2022. [PMID: 36129606 DOI: 10.1007/s12094-022-02922-8] [Reference Citation Analysis]
5 Tang L, Xie M, Li J, Mei Y, Cao Y, Xiao Q, Dong H, Zhang Y, Wang W. Leveraging nano-engineered mesenchymal stem cells for intramedullary spinal cord tumor treatment. Chinese Chemical Letters 2022. [DOI: 10.1016/j.cclet.2022.107801] [Reference Citation Analysis]
6 Tang L, Xiao Q, Yin Y, Mei Y, Li J, Xu L, Gao H, Wang W. An enzyme-responsive and NIR-triggered lipid-polymer hybrid nanoplatform for synergistic photothermal/chemo cancer therapy. Biomater Sci 2022. [PMID: 35383799 DOI: 10.1039/d2bm00216g] [Reference Citation Analysis]
7 Zhang Y, Huo L, Wei Z, Tang Q, Sui H. Hotspots and Frontiers in Inflammatory Tumor Microenvironment Research: A Scientometric and Visualization Analysis. Front Pharmacol 2022;13:862585. [PMID: 35370647 DOI: 10.3389/fphar.2022.862585] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Hou Z, Zhou W, Guo X, Zhong R, Wang A, Li J, Cen Y, You C, Tan H, Tian M. Poly(ϵ-Caprolactone)-Methoxypolyethylene Glycol (PCL-MPEG)-Based Micelles for Drug-Delivery: The Effect of PCL Chain Length on Blood Components, Phagocytosis, and Biodistribution. IJN 2022;Volume 17:1613-32. [DOI: 10.2147/ijn.s349516] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Chen X, Yung LL, Tan PH, Bay BH. Harnessing the Immunogenic Potential of Gold Nanoparticle-Based Platforms as a Therapeutic Strategy in Breast Cancer Immunotherapy: A Mini Review. Front Immunol 2022;13:865554. [DOI: 10.3389/fimmu.2022.865554] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Hsieh PH, Huang WY, Wang HC, Kuan CH, Shiue TY, Chen Y, Wang TW. Dual-responsive polypeptide nanoparticles attenuate tumor-associated stromal desmoplasia and anticancer through programmable dissociation. Biomaterials 2022;284:121469. [PMID: 35344799 DOI: 10.1016/j.biomaterials.2022.121469] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Li Y, Chen Z, Gu L, Duan Z, Pan D, Xu Z, Gong Q, Li Y, Zhu H, Luo K. Anticancer nanomedicines harnessing tumor microenvironmental components. Expert Opin Drug Deliv 2022. [PMID: 35244503 DOI: 10.1080/17425247.2022.2050211] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Tang L, He S, Yin Y, Li J, Xiao Q, Wang R, Gao L, Wang W. Combining nanotechnology with the multifunctional roles of neutrophils against cancer and inflammatory disease. Nanoscale 2022. [PMID: 35079756 DOI: 10.1039/d1nr07725b] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Bidar N, Darroudi M, Ebrahimzadeh A, Safdari M, de la Guardia M, Baradaran B, Goodarzi V, Oroojalian F, Mokhtarzadeh A. Simultaneous nanocarrier-mediated delivery of siRNAs and chemotherapeutic agents in cancer therapy and diagnosis: Recent advances. Eur J Pharmacol 2022;915:174639. [PMID: 34919890 DOI: 10.1016/j.ejphar.2021.174639] [Reference Citation Analysis]
14 Tang L, Zhang A, Zhang Z, Zhao Q, Li J, Mei Y, Yin Y, Wang W. Multifunctional inorganic nanomaterials for cancer photoimmunotherapy. Cancer Commun (Lond) 2022;42:141-63. [PMID: 35001556 DOI: 10.1002/cac2.12255] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
15 Parayath NN. Polymeric micelles as delivery systems for anticancer immunotherapy. Polymeric Micelles for Drug Delivery 2022. [DOI: 10.1016/b978-0-323-89868-3.00004-5] [Reference Citation Analysis]
16 Tang L, Xiao Q, Mei Y, He S, Zhang Z, Wang R, Wang W. Insights on functionalized carbon nanotubes for cancer theranostics. J Nanobiotechnology 2021;19:423. [PMID: 34915901 DOI: 10.1186/s12951-021-01174-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
17 Tang L, He S, Yin Y, Liu H, Hu J, Cheng J, Wang W. Combination of Nanomaterials in Cell-Based Drug Delivery Systems for Cancer Treatment. Pharmaceutics 2021;13:1888. [PMID: 34834304 DOI: 10.3390/pharmaceutics13111888] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 14.0] [Reference Citation Analysis]